According to Technavio’s latest market research study, the global women’s health diagnostics market is expected to grow at a CAGR of close to 7% during the forecast period, 2017-2021.
This report by Technavio provides an in-depth analysis of the global women’s health diagnostics market in terms of revenue and emerging market trends. The report also includes an up-to-date analysis and forecasts for various market segments and all geographical regions.
Technavio research analysts categorize the market based on the application type
Click here to request a free sample of this report
The top three revenue contributing application segments are discussed below
Global women’s health diagnostics market by cancer: The three main types of cancer covered in the women’s health diagnostics market include breast, cervical and ovarian cancer. Breast cancer is the most common form of cancer occurring in the female population across the world. Some of the factors leading to breast cancer are obesity, lack of physical exercise, alcohol consumption, menopausal changes, exposure to ionizing radiations, and genetic history. Mammography and biopsy tests are performed for breast cancer screening. The advent of biomarker technology is expected to favor the adoption of cancer screening among women across the globe during the forecast period.
“APAC has great potential in this market owing to the growing prevalence of cervical cancer in the region; however, lack of reimbursement will lower the adoption of HPV testing in the market. The development of low-cost products and organization of cervical cancer screening programs can help manufacturers increase their market share, leading to market growth,” says Barath Palada, a lead analyst at Technavio for research on in-vitro diagnostics.
Global women’s health diagnostics market by UTIs: UTIs are of two types –– hospital-acquired UTIs and community-acquired UTIs. Hospital-acquired UTIs are the most common type of infections in women. Conventional methods such as urine culture and urinalysis are widely used to diagnose UTIs. Increasing adoption of POCT devices coupled with the rising focus on disease management (such as early diagnosis) are factors that will facilitate the growth of the global women’s UTI diagnostics market.
Global women’s health diagnostics market by gynecology and fertility: The global women’s health gynecology and fertility testing market is still in its growth phase as people in developed economies are increasingly adopting pregnancy detection kits for the detection of pregnancies. Rapid urbanization is likely to propel the penetration of these products in emerging economies in the coming years. Demographic changes and the increase in awareness through social networks, Internet retailing, and other online forums are other factors that will fuel the adoption of POC home-based diagnostic tests in the global market over the next four years.
The top vendors operating in the global women’s health diagnostics market are:
- Abbott Laboratories
- F. Hoffmann-La Roche
- Hologic
- Siemens Healthineers
Other prominent vendors in the market include ACON Laboratories, Alere, Becton DickBulleted List Propertiesinson, bioMérieux, Bio-Rad Laboratories, Carl Zeiss Meditec, Cepheid, Danaher, Illumina, Mindray, Natera, Sysmex, Thermo Fisher Scientific, and Urit Medical.
A more detailed analysis is available in the Technavio report titled, ‘Global Women’s Health Diagnostics Market 2017-2021’. Technavio also customizes reports by other regions and specific segments upon request.
Other related reports
- Global HLA Typing Transplant Market 2017-2021
- Global Liquid Biopsy Market 2017-2021
- Global Influenza Diagnostics Market 2017-2021
To read more press releases – click here
